Hsbc Holdings PLC Invitae Corp Transaction History

Hsbc Holdings PLC

$145 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.42 - $0.72 $5,596 - $9,594	-13,326 Reduced 55.91%	10,508 $6,000
Q3 2023 Nov 13, 2023	SELL	$0.6 - $1.53 $1,806 - $4,605	-3,010 Reduced 11.21%	23,834 $14,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $1,371 - $2,895	-802 Reduced 2.9%	26,844 $49,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $92,554 - $420,393	-48,713 Reduced 63.79%	27,646 $70,000
Q2 2022 Aug 11, 2022	BUY	$2.13 - $9.01 $5,216 - $22,065	2,449 Added 3.31%	76,359 $191,000

Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $181,064 - $449,490	28,832 Added 63.96%	73,910 $598,000
Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $241,168 - $470,360	16,406 Added 57.22%	45,078 $688,000
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $1.47 Million - $2.03 Million	-60,513 Reduced 67.85%	28,672 $819,000
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $1.53 Million - $2.38 Million	58,791 Added 193.43%	89,185 $3.01 Million
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $594,319 - $1.02 Million	-17,977 Reduced 37.16%	30,394 $1.16 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $1.89 Million - $2.78 Million	48,371 New	48,371 $2.02 Million
Q2 2020 Aug 14, 2020	SELL	$11.71 - $30.29 $192,547 - $498,058	-16,443 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $38,872 - $139,920	5,088 Added 44.81%	16,443 $230,000
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $291,312 - $398,955	-19,395 Reduced 63.07%	11,355 $181,000
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $117,718 - $171,737	-6,245 Reduced 16.88%	30,750 $593,000
Q2 2019 Aug 13, 2019	BUY	$17.37 - $26.27 $642,603 - $971,858	36,995 New	36,995 $869,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account